The trademark application CATUVAB was filed by Lindis Blood Care GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 23, 2021, and it was registered by office on June 30, 2021 without any oppositions.
It was designated 'Basic Application' for International Application 1613130 at the World Intellectual Property Organization (WIPO).
The application was filed in German (English was selected as the second language).